Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

83.58 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
Despite Thursday's downside reversal, the major indexes had a solid advance. 
Via Investor's Business Daily
Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose... 
Via Benzinga
Why DexCom Shares Are Trading Higher Today
DexCom Inc (NASDAQ: DXCM) shares are trading higher after the company reported  
Via Benzinga
6 Analysts Have This to Say About DexCom
Via Benzinga
DexCom (DXCM) Q2 2023 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today
Via Benzinga
Top Picks: 3 Stocks That (Almost) All Analysts Agree On
While you shouldn’t rely on the word of analysts, sometimes they are the best stocks to buy for the long haul. 
Via InvestorPlace
Looking At DexCom's Recent Unusual Options Activity
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19
Looking for longs on the pullback in wave iv. 
Via Talk Markets
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
2 Growth Stocks That Could Double in 5 Years
They could deliver excellent returns well beyond that. 
Via The Motley Fool
A Look Into DexCom Inc's Price Over Earnings
Via Benzinga
Wall Street Believes These High-Profile Stock-Split Stocks Can Lose Up to 91% of Their Value
The low-water price targets provided by select analysts and Wall Street institutions suggest these widely owned stock-split stocks could plunge. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Nvidia And This AI Stock Lead 5 Names Near Buy Points
Nvidia has soared this year. Now its tight range has created a new buy point. 
Via Investor's Business Daily
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
Peering Into DexCom's Recent Short Interest
Via Benzinga
DexCom Unusual Options Activity For June 26
Via Benzinga
Where DexCom Stands With Analysts
Via Benzinga
Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada
DexCom, Inc.'s (NASDAQ: DXCM) next-generation  
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in July and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage, there's one phenomenal value and another top performer that's arguably never been this pricey. 
Via The Motley Fool
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers
Via Benzinga
Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest change in net assets on the week, according to... 
Via Benzinga
DexCom Revises 2025 Outlook, Announces New Product For Diabetics
DexCom Inc (NASDAQ: DXCM) disclosed the 2025 financial targets revision at  
Via Benzinga
DexCom Unusual Options Activity
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29
Looking for upside into wave {iii} as long as we don’t break the bottom of wave {ii}. 
Via Talk Markets
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
The company makes continuous glucose monitors for patients with diabetes. 
Via Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $74,000 Today
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc, June 20
Looking for a correction in wave (ii) as we seem to be extending higher into wave {iii}. We successfully broke the previous top of wave {i} to confirm further upside. 
Via Talk Markets
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.